Correlation
The correlation between CLOV and LUMN is 0.35, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
CLOV vs. LUMN
Compare and contrast key facts about Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CLOV or LUMN.
Performance
CLOV vs. LUMN - Performance Comparison
Loading data...
Key characteristics
CLOV:
2.57
LUMN:
1.53
CLOV:
3.36
LUMN:
3.28
CLOV:
1.41
LUMN:
1.40
CLOV:
2.23
LUMN:
2.18
CLOV:
11.55
LUMN:
5.36
CLOV:
18.44%
LUMN:
38.67%
CLOV:
80.32%
LUMN:
133.62%
CLOV:
-97.16%
LUMN:
-95.26%
CLOV:
-85.68%
LUMN:
-81.13%
Fundamentals
CLOV:
$1.63B
LUMN:
$4.12B
CLOV:
-$0.04
LUMN:
-$0.32
CLOV:
1.10
LUMN:
0.32
CLOV:
4.86
LUMN:
13.99
CLOV:
$1.49B
LUMN:
$13.00B
CLOV:
$391.93M
LUMN:
$5.52B
CLOV:
-$22.89M
LUMN:
$3.77B
Returns By Period
In the year-to-date period, CLOV achieves a -0.63% return, which is significantly higher than LUMN's -26.55% return.
CLOV
-0.63%
-9.28%
-8.48%
203.88%
4.92%
N/A
N/A
LUMN
-26.55%
9.24%
-47.08%
202.33%
-31.64%
-13.67%
-13.68%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CLOV vs. LUMN — Risk-Adjusted Performance Rank
CLOV
LUMN
CLOV vs. LUMN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
CLOV vs. LUMN - Dividend Comparison
Neither CLOV nor LUMN has paid dividends to shareholders.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CLOV Clover Health Investments, Corp. | 0.00% | 0.00% | 0.00% | 0.00% | 2.69% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
LUMN Lumen Technologies, Inc. | 0.00% | 0.00% | 0.00% | 14.37% | 7.97% | 10.26% | 7.57% | 14.26% | 12.95% | 9.08% | 8.59% | 5.46% |
Drawdowns
CLOV vs. LUMN - Drawdown Comparison
The maximum CLOV drawdown since its inception was -97.16%, roughly equal to the maximum LUMN drawdown of -95.26%. Use the drawdown chart below to compare losses from any high point for CLOV and LUMN.
Loading data...
Volatility
CLOV vs. LUMN - Volatility Comparison
Clover Health Investments, Corp. (CLOV) and Lumen Technologies, Inc. (LUMN) have volatilities of 18.32% and 18.62%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
CLOV vs. LUMN - Financials Comparison
This section allows you to compare key financial metrics between Clover Health Investments, Corp. and Lumen Technologies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CLOV vs. LUMN - Profitability Comparison
CLOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a gross profit of 108.89M and revenue of 462.33M. Therefore, the gross margin over that period was 23.6%.
LUMN - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Lumen Technologies, Inc. reported a gross profit of 1.50B and revenue of 3.18B. Therefore, the gross margin over that period was 47.0%.
CLOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported an operating income of -1.27M and revenue of 462.33M, resulting in an operating margin of -0.3%.
LUMN - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Lumen Technologies, Inc. reported an operating income of 107.00M and revenue of 3.18B, resulting in an operating margin of 3.4%.
CLOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Clover Health Investments, Corp. reported a net income of -1.27M and revenue of 462.33M, resulting in a net margin of -0.3%.
LUMN - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Lumen Technologies, Inc. reported a net income of -201.00M and revenue of 3.18B, resulting in a net margin of -6.3%.